Avience Biomedicals SME IPO Details
Avience Biomedicals IPO was open for subscription from 18 June 2026 to 22 June 2026. Incorporated in 2019, Avience Biomedicals Limited is a molecular diagnostics and biomedical products company focused on healthcare testing solutions. The company follows a business model centred on manufacturing and supplying diagnostic kits, reagents and laboratory products for healthcare institutions. Based in Noida, the company serves hospitals, diagnostic laboratories and healthcare providers across India
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Avience Biomedicals
IPO Summary
What is the Avience Biomedicals IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 18 Jun, 2026 Thu | Thursday |
| IPO Close Date | 22 Jun, 2026 Mon | Monday |
| Basis of Allotment | 23 Jun, 2026 Tue | Tuesday |
| Refunds Initiated | 24 Jun, 2026 Wed | Wednesday |
| Credit to Demat | 24 Jun, 2026 Wed | Wednesday |
| Listing Date | 25 Jun, 2026 Thu | Thursday |
What is the Avience Biomedicals IPO Lot Size?
Bidding in multiples of 600 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 1200 | ₹2,49,600 |
| Retail (Max) | 2 | 1200 | ₹2,49,600 |
| HNI (Min) | 3 | 1800 | ₹3,74,400 |
About Avience Biomedicals
The company is engaged in the manufacturing and distribution of molecular diagnostic kits, reagents and related healthcare products used by hospitals, laboratories and diagnostic centres. Its business model is based on developing and supplying testing solutions that support disease detection and clinical diagnostics. With increasing demand for advanced healthcare testing infrastructure, the company aims to expand its product portfolio and market reach across India.
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
Strengths & Risks
Strengths
- ✓ Operates in the fast-growing healthcare and molecular diagnostics sector.
- ✓ Focused product portfolio catering to hospitals and diagnostic laboratories.
- ✓ Rising demand for diagnostic testing supports long-term growth prospects.
- ✓ Experienced promoter group with healthcare industry exposure.
- ✓ Asset-backed manufacturing and distribution capabilities enhance scalability.
Risks
- ⚠ Business performance depends on regulatory approvals and healthcare compliance requirements.
- ⚠ Intense competition from established diagnostic and biomedical companies may affect growth.
- ⚠ Rapid technological changes could require continuous investment in product development.
- ⚠ Dependence on healthcare spending and diagnostic testing demand may impact revenues.
- ⚠ Relatively limited operating history compared to larger industry peers.
Company Financials
Summary of financial performance including revenue, profit, and debt levels will be populated here.
Promoters and Shareholding Details
Promoter holding details will be updated as soon as they are officially announced.
Frequently Asked Questions
What is the GMP of Avience Biomedicals?
The current Grey Market Premium (GMP) of Avience Biomedicals is ₹ 145.
What is the Avience Biomedicals IPO Price Band?
The price band for Avience Biomedicals IPO is 208.
When is the Avience Biomedicals IPO Allotment?
The allotment date for Avience Biomedicals IPO is June 23, 2026.
How to check Avience Biomedicals IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Skyline Financial Services Private Limited).
Discussion 0
No comments yet
Be the first to share your thoughts!